The ADAMs family of proteins: From basic studies to potential clinical applications

Miachel J. Duffy, David J. Lynn, Andrew T. Lloyd, Caroline M. O'Shea

Research output: Contribution to journalReview articlepeer-review

64 Citations (Scopus)


The ADAMs are a family of membrane proteins possessing a disintegrin and metalloprotease domain. Currently, 34 members are known to exist. Approximately 50% of the ADAMs contain a metalloprotease-like domain and some of these have been shown to possess protease activity. Most of the protein substrates identified to date for ADAMs are either integral membrane or extracellular matrix (ECM) proteins. In addition to hydrolysing proteins, a number of ADAMs bind to integrins. The attachment to integrins occurs via the disintegrin domain. Since the ADAMs can play a role in both proteolysis and adhesion, they have been implicated in a variety of biological processes such as sperm-egg fusion, somatic cell-cell adhesion, ectodomain shedding, myoblast fusion and development. Altered expression of certain ADAMs has been associated with a number of diseases including asthma, arthritis, Alzheimer's disease, atherosclerosis and cancer.

Original languageEnglish
Pages (from-to)622-631
Number of pages10
JournalThrombosis and Haemostasis
Issue number4
Publication statusPublished or Issued - 1 Apr 2003
Externally publishedYes


  • ADAMs cell adhesion
  • Disease and metalloproteinases

ASJC Scopus subject areas

  • Hematology

Cite this